DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Zhou C, Wu Y-L, Chen G. et al.
BEYOND: a randomized, double-blind, placebo-controlled, multicenter, phase iii study of first-line carboplatin/paclitaxel plus bevacizumab or placebo in chinese patients with advanced or recurrent nonsquamous non-small-cell lung cancer.
J Clin Oncol 2015;
33 (19) 2197-2204
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.